DEFINITION OF THE HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA PATIENT BY IMMUNOLOGICAL PHENOTYPING WITH MONOCLONAL-ANTIBODIES

被引：0
|
作者：
ZIPF, TF
FOX, RI
DILLEY, J
LEVY, R
机构：
[1] STANFORD UNIV,MED CTR,SCH MED,DEPT MED ONCOL,STANFORD,CA 94305
[2] STANFORD UNIV,MED CTR,SCH MED,DEPT PEDIAT,STANFORD,CA 94305
[3] STANFORD UNIV,MED CTR,SCH MED,HOWARD HUGHES MED INST LABS,STANFORD,CA 94305
[4] STANFORD UNIV,CHILDRENS HOSP,DIV HEMATOL ONCOL,STANFORD,CA 94305
来源：
CANCER RESEARCH | 1981年 / 41卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4786 / 4789
页数：4
相关论文
共 50 条
  • [41] PRECLINICAL STUDY OF A PANEL OF MONOCLONAL-ANTIBODIES (MOAB) WITH A VIEW TO INVITRO PURGING IN ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)
    HERVE, P
    RACADOT, E
    LEBACQ, AM
    LAMY, B
    PETERS, A
    INTERNATIONAL JOURNAL OF CELL CLONING, 1985, 3 (04): : 276 - 276
  • [42] MONOCLONAL-ANTIBODIES AND COMPLEMENT PURGED AUTOGRAFT IN BURKITT-LYMPHOMA AND LYMPHOBLASTIC-LEUKEMIA
    FAVROT, M
    PHILIP, I
    COMBARET, V
    PAVONE, E
    BOUFFET, E
    BIRON, P
    PHILIP, T
    BONE MARROW TRANSPLANTATION, 1989, 4 : 202 - 204
  • [43] AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA - DEPLETION OF LEUKEMIC-CELLS FROM THE GRAFT USING MONOCLONAL-ANTIBODIES AND HUMAN-COMPLEMENT
    WIESNETH, M
    HERTENSTEIN, B
    GREHER, J
    SCHMEISER, T
    ARNOLD, R
    KOERNER, K
    KNAPP, W
    HEIMPEL, H
    HEIT, W
    BLUT, 1986, 53 (03): : 184 - 184
  • [44] A COMPREHENSIVE ASSESSMENT OF OUTCOMES FOR SURVIVORS OF HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)
    FEENY, D
    BARR, RD
    LEIPER, A
    FURLONG, W
    TORRANCE, G
    ROSENBAUM, P
    ZHANG, YM
    HORSMAN, J
    WEITZMAN, S
    PEDIATRIC RESEARCH, 1990, 27 (04) : A141 - A141
  • [45] SUPERIOR TREATMENT RESULTS IN FEMALES WITH HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDHOOD
    LANNING, M
    GARWICZ, S
    HERTZ, H
    JONMUNDSSON, G
    KREUGER, A
    LIE, SO
    MOE, PJ
    SALMI, TT
    SCHRODER, H
    SIIMES, MA
    WESENBERG, F
    YSSING, M
    AHSTROM, L
    GUSTAFSSON, G
    ACTA PAEDIATRICA, 1992, 81 (01) : 66 - 68
  • [46] INTENSIFICATION OF INITIAL TREATMENT IN STANDARD AND HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDREN
    ORTEGA, JJ
    MEDICAL AND PEDIATRIC ONCOLOGY, 1988, 16 (06): : 390 - 390
  • [47] IMMUNOLOGICAL APPROACH TO THE TREATMENT OF ACUTE LYMPHOBLASTIC-LEUKEMIA
    BERGOLZ, VM
    KISLJAK, NS
    EREMEEV, VS
    RUMJANTZEV, AG
    AKIMOVA, GV
    OSIPOV, SG
    NEOPLASMA, 1980, 27 (04) : 355 - 361
  • [48] IMMUNOLOGICAL AND MOLECULAR CLASSIFICATION OF ACUTE LYMPHOBLASTIC-LEUKEMIA
    FOA, R
    MIGONE, N
    GAVOSTO, F
    HAEMATOLOGICA, 1986, 71 (04) : 277 - 285
  • [49] IMMUNOLOGICAL MARKERS IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA
    BOROWITZ, MJ
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1990, 4 (04) : 743 - 765
  • [50] EFFECTS OF MONOCLONAL-ANTIBODIES RAISED AGAINST THE COMMON ACUTE LYMPHOBLASTIC-LEUKEMIA ANTIGEN ON ENDOPEPTIDASE-24.11 ACTIVITY
    HELENE, A
    MILHIET, PE
    HAOUAS, H
    BOUCHEIX, C
    BEAUMONT, A
    ROQUES, BP
    BIOCHEMICAL PHARMACOLOGY, 1992, 43 (04) : 809 - 814
12345